SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-009891
Filing Date
2017-05-09
Accepted
2017-05-09 16:27:12
Documents
3
Period of Report
2017-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - Q1 EARNINGS RELEASE xene-8k_20170509.htm 8-K 32544
2 EX-99.1 xene-ex991_6.htm EX-99.1 155954
3 GRAPHIC g20170509162627736159.jpg GRAPHIC 5126
  Complete submission text file 0001564590-17-009891.txt   196818
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 17826812
SIC: 2834 Pharmaceutical Preparations